drugset / Trial / NCT02331134

Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer

NCT02331134

NaSingle-groupOpen-labelBasic science

Summary

The overall goal of this study is to develop a pre-clinical platform of melanoma and head and neck squamous cell cancer that will allow the investigators to learn more about these diseases and discover better and more individualized treatments.

Timeline

Start
2015-05-13
Primary completion
2018-07-06
Completion
2025-03-06

Drugs

EvaluationDrugModalityDoseRoute
Background filgrastim Protein / enzyme biologic 10 ug/kg Subcutaneous